MARKET

TLOG

TLOG

Tetralogic
EXMKT
0.0001
NaN%
Closed 09:30 03/21 EDT
OPEN
--
PREV CLOSE
0.0001
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.0001
52 WEEK LOW
0.0001
MARKET CAP
2.48K
P/E (TTM)
-0.0001
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at TLOG last week (0310-0314)?
Weekly Report · 6d ago
Weekly Report: what happened at TLOG last week (0303-0307)?
Weekly Report · 03/10 10:17
Weekly Report: what happened at TLOG last week (0224-0228)?
Weekly Report · 03/03 10:17
Weekly Report: what happened at TLOG last week (0217-0221)?
Weekly Report · 02/24 10:17
Weekly Report: what happened at TLOG last week (0210-0214)?
Weekly Report · 02/17 10:15
Weekly Report: what happened at TLOG last week (0203-0207)?
Weekly Report · 02/10 10:12
Weekly Report: what happened at TLOG last week (0127-0131)?
Weekly Report · 02/03 10:14
Weekly Report: what happened at TLOG last week (0120-0124)?
Weekly Report · 01/27 10:16
More
About TLOG
TetraLogic Pharmaceuticals Corporation is a clinical-stage biopharmaceutical company. The Company is focused on discovering and developing small molecule therapeutics in oncology, infectious diseases and autoimmune diseases. The Company's segment is the identification and development of novel small molecule therapies in oncology and infectious diseases. The Company has approximately two clinical-stage product candidates in development, such as birinapant and SHAPE. SHAPE is the Company's histone deacetylase (HDAC) inhibitor that it is developing for topical use for the treatment of early-stage cutaneous T-cell lymphoma (CTCL). The Company is also exploring studying SHAPE in alopecia areata, an autoimmune skin disease. SHAPE has been granted the United States orphan drug designation for CTCL. Birinapant is a small molecule therapeutic that mimics Second Mitochondrial Activator of Caspases (SMAC)-mimetic, which leads to apoptosis or cell-death in damaged cells.

Webull offers Tetralogic Pharmaceuticals Corp stock information, including EXMKT: TLOG real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TLOG stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TLOG stock methods without spending real money on the virtual paper trading platform.